Search clinical trials for: Rituximab (Rituxan)
Total 3362 results
-
M.D. Anderson Cancer CenterCompletedLymphoma | Leukemia | MyelomaUnited States
-
Stanford UniversityCompleted
-
University Hospital ErlangenCompletedLymphoma | LeukemiaGermany, Switzerland
-
CelltrionCompletedRheumatoid ArthritisKorea, Republic of
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedLymphomaUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
BiogenCompletedLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaUnited States, Canada
-
BiogenTerminated
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Canada, Spain, Taiwan, France, Australia, United Kingdom, Poland, Italy, Israel, Czechia, Germany, Russian Federation, Sweden
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Terminated
-
Andres J. M. FerreriCompletedOcular Adnexal Mucosa-Associated Lymphoid Tissue LymphomaItaly
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
Papworth Hospital NHS Foundation TrustCompletedMyocardial Infarction | Inflammation | Ischemic Heart DiseaseUnited Kingdom
-
Swiss Group for Clinical Cancer ResearchCompletedLymphomaSwitzerland, South Africa, Italy, Brazil, North Macedonia, Serbia, Slovakia
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Follicular Lymphoma or Mantle Cell LymphomaKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Beijing Friendship HospitalRecruitingChronic Active Epstein-Barr Virus Infection | Secondary Hemophagocytic LymphohistiocytosisChina
-
Cogent Biosciences, Inc.Terminated
-
Cogent Biosciences, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
International Extranodal Lymphoma Study Group (IELSG)Withdrawn
-
Ostfold Hospital TrustOslo University Hospital; South-Eastern Regional Health AuthorityCompleted
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
German High-Grade Non-Hodgkin's Lymphoma Study...Deutsche Krebshilfe e.V., Bonn (Germany)CompletedNon-Hodgkin's Lymphoma (NHL)Germany
-
CelltrionCompleted
-
Kite, A Gilead CompanyCompletedRefractory Large B-cell LymphomaUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruitingPrimary Membranous NephropathyChina
-
CelgeneThe Lymphoma Academic Research OrganisationCompletedFollicular LymphomaJapan, United States
-
University College, LondonRoche Pharma AG; Cancer Research UKCompletedLymphomaNew Zealand, United Kingdom, Australia
-
Assistance Publique - Hôpitaux de ParisGlaxoSmithKlineRecruitingPrimary Immune Thrombocytopenia (ITP)France
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular... and other conditionsUnited States
-
Laida Cuevas PalomaresRecruiting
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Cedars-Sinai Medical CenterGenentech, Inc.; BiogenCompletedKidney TransplantUnited States
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingMALT LymphomaSwitzerland, Italy, France
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 PositiveUnited States
-
Genentech, Inc.Seagen Inc.Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedLymphoma | Leukemia | Lymphoproliferative DisorderUnited States
-
Duke UniversityGlaxoSmithKlineCompletedLymphoma, B-CellUnited States
-
Fate TherapeuticsTerminatedLymphoma, B-Cell | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B Chronic Lymphocytic LeukemiaUnited States
-
Ohio State University Comprehensive Cancer CenterAstex Pharmaceuticals, Inc.CompletedB-Chronic Lymphocytic LeukemiaUnited States